Quadria Capital, a healthcare-focused private equity firm based in Singapore, has announced the final close of its Fund III with US$1.07 billion in total commitments, exceeding its original US$800 million target.

The fundraise comprises over US$954 million in primary commitments and US$114 million in committed co-investment capital. An additional US$300 million co-investment capacity is expected during the investment phase, bringing total committed capital to approximately US$1.3 billion upon full deployment.

The latest fundraising round is about 60% larger than the firm’s previous US$600 million fund raised in 2020.

Co-founder and managing partner Abrar Mir says the oversubscription “reflects deep global investor conviction in the transformational opportunity in Asian healthcare, where social impact and financial performance go hand in hand”.

Quadria Capital’s largest backers include prominent North American and European sovereign wealth funds, asset managers, and strategic corporates. The fund also secured new commitments from globally recognized institutional investors. There was strong backing from leading institutions across the Gulf Cooperation Council, including Saudi Arabia, the United Arab Emirates, and Bahrain.

The fundraise also attracted interest from India, with fresh capital from major banks, insurance companies, and family offices. Additionally, the fund received robust re-up commitments from impact investors, underscoring Quadria’s continued dedication to scalable, high-impact healthcare businesses that deliver lifesaving care to underserved populations across Asia, the company says.

“With Asia expected to drive 40% of global healthcare growth by 2030, Fund III positions Quadria to lead a new era of private capital-driven healthcare transformation across the region,” Mir adds.